Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1
Release Date: 07/27/2026
Neurology® Podcast
In part one of this two-part series, recorded at this year's AAN Annual Meeting, Dr. Gregg Day talks with Drs. Joel Salinas and Sarah Song about the evolving landscape of brain health, practical approaches to incorporating brain health assessments into routine care, and the importance of collaboration across specialties. Visit the newly launched to access trusted brain health information and stay informed. Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Justin Abbatemarco talks with Drs. Sara Marceglia and Alberto Priori about the use of artificial intelligence in neurology training, highlighting the need for formal curricula, ethical considerations, and practical applications in clinical practice. Read the related article in Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Aaron Zelikovich talks with Dr. Bhaskar Roy about the latest treatments for myasthenia gravis, comparing their efficacy and safety. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Aaron Zelikovich talks with Dr. Bhaskar Roy about the latest treatments for myasthenia gravis, comparing their efficacy and safety. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
The September 2026 Recall features four previously posted episodes highlighting updates in child neurology. The episode begins with Dr. Andrew Hershey discussing advances in the treatment of pediatric migraines. Next, Dr. Serena Orr discusses the genetic risk of migraine and post-traumatic headache in children. In the third episode, Dr. Coral Stredny reviews the management of pediatric convulsive status epilepticus, with a focus on seizure action plans and adherence to treatment protocols. The episode concludes with Dr. Scott Perry discussing approaches to improving the transition from...
info_outlineNeurology® Podcast
Dr. Jason Crowell talks with Ka-Ho Wong about national trends in Medicare reimbursement for inpatient neurologic care, including the widening gap between hospital charges and payments and its implications for healthcare policy. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
In part two of this series on the 2026 Alzheimer Association International Conference, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about recent clinical trials, evolving treatment strategies, and prevention efforts. Disclosures can be found at .
info_outlineNeurology® Podcast
In part one of this series, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about blood-based biomarkers, anti-amyloid therapies, and other highlights from the 2026 Alzheimer Association International Conference. Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Shuvro Roy talks with Prof. Catherine Jutzeler about how age influences neurologic and functional recovery after spinal cord injury and how these findings could inform treatment and future clinical trials. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Greg Cooper talks with Dr. Chloe Hill about comparing virtual and in-person neurology outpatient visits for new patients. Read the related article in . Disclosures can be found at .
info_outlineIn part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data.
For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.
Read more about the Fenebrutinib Trial.
Disclosures can be found at Neurology.org.